- Pharmaceutical companies are adopting AI for clinical data gathering, product promotion, and prototyping.
- Pharmaceutical companies are adopting AI for clinical data gathering, product promotion, and prototyping.
- Pharmaceutical companies are adopting AI for clinical data gathering, product promotion, and prototyping.
- Pharmaceutical companies, including Amgen and AstraZeneca, are adopting AI tools for clinical data gathering and drug development.
AstraZeneca partners with Modella AI to accelerate AI-driven clinical development.
1 report, 0 independent
Updated Jul 9
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
AstraZeneca partners with Modella AI to accelerate AI-driven clinical development.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
AstraZeneca
British-Swedish pharmaceutical company
Related events
- AbbVie, AstraZeneca, and Bristol-Myers Squibb collaborated on the AISB Bind AI initiative.
- Alnylam Pharmaceuticals announced new partnerships with AstraZeneca for drug development and with Ionis Pharmaceuticals for clinical trials.
- AstraZeneca and Innate Pharma S.A. are collaborating on developing a lead pharmaceutical program.
Coverage
Newest first; wire copies grouped- Unknown outlet